Endogenous

Overview

Endogenous (from Greek endon, "within," and genein, "to produce") describes any substance, process, or condition that originates from within an organism. In pharmacology and peptide science, the term most commonly refers to molecules that the body synthesizes naturally as part of its normal physiological processes — as distinguished from exogenous substances that are introduced from outside.

Understanding whether a compound is endogenous or exogenous is fundamental to peptide research, as it shapes expectations around receptor compatibility, immune recognition, safety profiles, and regulatory mechanisms.

Detailed Explanation

Endogenous Molecules in Context

The human body produces thousands of endogenous peptides and proteins that regulate virtually every physiological system:

Endogenous Hormones Hormones are signaling molecules produced by endocrine glands and transported through the bloodstream to target tissues. Examples include insulin (produced by pancreatic beta cells), growth hormone (produced by the anterior pituitary), and cortisol (produced by the adrenal cortex).

Endogenous Peptides The body synthesizes a vast array of peptides for signaling, defense, and regulation:

• Neuropeptides: Endorphins, enkephalins, substance P, and oxytocin function as neurotransmitters or neuromodulators in the nervous system.
• Cytokines: Interleukins, interferons, and tumor necrosis factors coordinate immune responses.
• Growth factors: VEGF, EGF, IGF-1, and others regulate cell proliferation and tissue repair.
• Antimicrobial peptides: Defensins and cathelicidins provide innate immune defense against pathogens.

Endogenous Enzymes Proteases, kinases, phosphatases, and other enzymes are endogenous proteins that catalyze biochemical reactions, including the proteolysis that degrades peptides.

Endogenous vs. Exogenous: Why It Matters

The distinction between endogenous and exogenous compounds has several important implications:

Feedback and Homeostasis

Endogenous compounds are typically regulated by negative feedback loops that maintain homeostatic balance. When endogenous levels of a hormone rise above a setpoint, the body reduces production. When an exogenous version of the same compound is administered, it may suppress endogenous production through these same feedback mechanisms — a critical consideration in peptide research protocols.

For example, exogenous administration of growth hormone suppresses endogenous GH secretion through negative feedback on the hypothalamic-pituitary axis. Growth hormone secretagogues (like Ipamorelin or GHRP-6) take a different approach — they stimulate the body's own endogenous GH production rather than replacing it, which may better preserve the natural pulsatile release pattern and feedback regulation.

Relevance to Peptide Research

Many research peptides are synthetic analogs of endogenous compounds:

BPC-157 is a synthetic peptide based on a sequence found within the endogenous protein Body Protection Compound, which is naturally present in human gastric juice. While the full parent protein is endogenous, the specific 15-amino acid fragment used in research (BPC-157) is a synthetic construct that does not occur naturally at pharmacological concentrations.

Thymosin beta-4 — the parent molecule of TB-500 — is an endogenous protein present in virtually all human cells, where it plays roles in actin polymerization, cell migration, and wound healing. The research peptide TB-500 represents the active fragment of this endogenous protein.

GHK-Cu is a naturally occurring endogenous tripeptide found in human plasma, saliva, and urine. Plasma levels of endogenous GHK decline significantly with age — from approximately 200 ng/mL at age 20 to 80 ng/mL by age 60 — which has driven interest in exogenous supplementation.

The endogenous origin of these compounds is often cited as a factor in their expected tolerability, as the body already possesses the receptor machinery and degradation pathways to handle these molecular structures.

Examples

Growth hormone-releasing hormone (GHRH) is an endogenous 44-amino acid peptide produced by the hypothalamus. CJC-1295 (Mod GRF 1-29) is a synthetic analog of the first 29 residues of endogenous GHRH, modified to resist enzymatic degradation and extend half-life.

Ghrelin is an endogenous 28-amino acid peptide produced primarily in the stomach that acts as a natural receptor agonist at the growth hormone secretagogue receptor. Synthetic GHSR agonists like GHRP-6 and Ipamorelin mimic ghrelin's receptor activation without replicating its full endogenous structure.

Related Terms

The opposite of endogenous is exogenous. Endogenous peptides include neuropeptides, growth factors, and cytokines. Many research peptides function as receptor agonists that mimic the activity of endogenous ligands. The body's endogenous enzymes carry out proteolysis that degrades both endogenous and exogenous peptides.